Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...

The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...

The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

Eli Lilly will invest over $1.2bn into its manufacturing site in Puerto Rico, as it aims to assemble a robust supply chain ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

Health Canada has issued a Notice of Compliance (NOC) for AstraZeneca’s HER2-directed antibody drug conjugate (ADC) Enhertu.

While Pfizer called the bid “reckless”, Metsera disagrees, stating that it will review the “superior proposal”.

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.

The grant is intended to develop and produce an oral liquid version of SER-155. Credit: YURIMA/Shutterstock.com. Seres ...